127 related articles for article (PubMed ID: 30609164)
1. MRI analysis of fecal volume and dryness: Validation study using an experimental oxycodone-induced constipation model.
Mark EB; Bødker MB; Grønlund D; Østergaard LR; Frøkjaer JB; Drewes AM
J Magn Reson Imaging; 2019 Sep; 50(3):733-745. PubMed ID: 30609164
[TBL] [Abstract][Full Text] [Related]
2. Although tapentadol and oxycodone both increase colonic volume, tapentadol treatment resulted in softer stools and less constipation: a mechanistic study in healthy volunteers.
Mark EB; Frøkjær JB; Hansen TM; Nedergaard RB; Drewes AM
Scand J Pain; 2021 Apr; 21(2):406-414. PubMed ID: 33606931
[TBL] [Abstract][Full Text] [Related]
3. Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI.
Nilsson M; Poulsen JL; Brock C; Sandberg TH; Gram M; Frøkjær JB; Krogh K; Drewes AM
Eur J Gastroenterol Hepatol; 2016 May; 28(5):514-24. PubMed ID: 26795566
[TBL] [Abstract][Full Text] [Related]
4. Short-term oxycodone treatment does not affect electrogenic ion transport in isolated mucosa from the human rectosigmoid colon.
Nilsson M; Brock C; Poulsen JL; Bindslev N; Hansen MB; Louring Christrup L; Drewes AM
Scand J Gastroenterol; 2016; 51(5):538-47. PubMed ID: 26610166
[TBL] [Abstract][Full Text] [Related]
5. Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers.
Mark EB; Nedergaard RB; Hansen TM; Nissen TD; Frøkjaer JB; Scott SM; Krogh K; Drewes AM
Neurogastroenterol Motil; 2021 Nov; 33(11):e14131. PubMed ID: 34051122
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system: Effect of opioids.
Mark EB; Klinge MW; Grønlund D; Poulsen JL; Schlageter V; Scott SM; Krogh K; Drewes AM
Neurogastroenterol Motil; 2020 Mar; 32(3):e13753. PubMed ID: 31721398
[TBL] [Abstract][Full Text] [Related]
7. Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.
Poulsen JL; Brock C; Grønlund D; Liao D; Gregersen H; Krogh K; Drewes AM
Dig Dis Sci; 2017 Nov; 62(11):3156-3166. PubMed ID: 28986667
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging.
Major G; Murray K; Singh G; Nowak A; Hoad CL; Marciani L; Silos-Santiago A; Kurtz CB; Johnston JM; Gowland P; Spiller R
Neurogastroenterol Motil; 2018 Sep; 30(9):e13400. PubMed ID: 30062794
[TBL] [Abstract][Full Text] [Related]
9. The impact of naloxegol on anal sphincter function - Using a human experimental model of opioid-induced bowel dysfunction.
Grønlund D; Poulsen JL; Krogh K; Brock C; Liao D; Gregersen H; Drewes AM; Olesen AE
Eur J Pharm Sci; 2018 May; 117():187-192. PubMed ID: 29432808
[TBL] [Abstract][Full Text] [Related]
10. Comparison of subjective and objective measures of constipation - Employing a new method for categorizing gastrointestinal symptoms.
Grønlund D; Vase L; Knudsen SA; Christensen M; Drewes AM; Olesen AE
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):23-28. PubMed ID: 30149126
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
[TBL] [Abstract][Full Text] [Related]
12. A novel semi-automatic segmentation method for volumetric assessment of the colon based on magnetic resonance imaging.
Sandberg TH; Nilsson M; Poulsen JL; Gram M; Frøkjær JB; Østergaard LR; Drewes AM
Abdom Imaging; 2015 Oct; 40(7):2232-41. PubMed ID: 26054979
[TBL] [Abstract][Full Text] [Related]
13. Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.
Etropolski M; Kelly K; Okamoto A; Rauschkolb C
Adv Ther; 2011 May; 28(5):401-17. PubMed ID: 21494892
[TBL] [Abstract][Full Text] [Related]
14. Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.
Simpson K; Leyendecker P; Hopp M; Müller-Lissner S; Löwenstein O; De Andrés J; Troy Ferrarons J; Bosse B; Krain B; Nichols T; Kremers W; Reimer K
Curr Med Res Opin; 2008 Dec; 24(12):3503-12. PubMed ID: 19032132
[TBL] [Abstract][Full Text] [Related]
15. The MRI colonic function test: Reproducibility of the Macrogol stimulus challenge.
Wilkinson-Smith V; Menys A; Bradley C; Corsetti M; Marciani L; Atkinson D; Coupland C; Taylor SA; Gowland P; Spiller R; Hoad C
Neurogastroenterol Motil; 2020 Nov; 32(11):e13942. PubMed ID: 32677154
[TBL] [Abstract][Full Text] [Related]
16. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
Hale ME; Dvergsten C; Gimbel J
J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
[TBL] [Abstract][Full Text] [Related]
18. Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.
Haeseler G; Schaefers D; Prison N; Ahrens J; Liu X; Karch A
BMC Anesthesiol; 2017 Jul; 17(1):91. PubMed ID: 28693439
[TBL] [Abstract][Full Text] [Related]
19. Effects of Naloxegol on Gastrointestinal Transit and Colonic Fecal Volume in Healthy Participants Receiving Oxycodone.
Olesen AE; Grønlund D; Mark EB; Krogh K; Frøkjær JB; Drewes AM
J Neurogastroenterol Motil; 2019 Oct; 25(4):602-610. PubMed ID: 31587551
[TBL] [Abstract][Full Text] [Related]
20. Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment.
Koopmans-Klein G; Van Op den Bosch J; van Megen Y; Prenen H; Huygen F; Mancini I
Curr Med Res Opin; 2017 Dec; 33(12):2217-2227. PubMed ID: 28805471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
